Leaflet CORIPREN 20mg / 20mg film-coated tablets
Indicated for: hypertension
Route of administration: oral
Substance: enalapril + lercanidipine (ACE inhibitor + calcium channel blocker)
ATC: C09BB02 (Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers)
Do not use this medicine during pregnancy.
May lower blood pressure and increase the risk of falls.
This medicine may have important interactions with other medicines.
Periodic laboratory tests may be required during treatment.
This medicine may change blood electrolyte levels.
The combination of Enalapril + lercanidipine is used for the treatment of essential hypertension in patients requiring combination therapy. It combines an angiotensin-converting enzyme (ACE) inhibitor (enalapril) with a calcium channel blocker (lercanidipine) to lower blood pressure.
The medication is taken orally, usually once daily, and is effective in reducing the risk of cardiovascular complications such as stroke or heart attack.
Side effects may include dizziness, headache, peripheral edema, dry cough, or nausea. It is important to monitor blood pressure and kidney function during treatment.
Consult your doctor to discuss the benefits and risks of treatment with this combination. Follow the prescribed dosage and adhere to all medical recommendations.
General data about CORIPREN 20mg / 20mg
- Substance: enalapril + lercanidipine
- Date of latest medicines list: 01-01-2015
- Product code: W61014001
- Concentration: 20mg / 20mg
- Pharmaceutical form: film-coated tablets
- Quantity: 7
- Product type: Original
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Concentrations available for enalapril + lercanidipine
- 10mg/10mg
- 20mg/10mg
- 20mg/20mg